Condition
Syncope, Vasovagal, Neurally-Mediated
Total Trials
5
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Completed4
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06697145Not ApplicableCompletedPrimary
Assessment of the Durability of Cardioneuroablation Using Physiological Indices of Heart Rate Reactivity
NCT06513650RecruitingPrimary
Mechanism-based Therapy of Hypotensive Syncope
NCT00118482Phase 4CompletedPrimary
Clinical Trial for the Prevention of Vasovagal Syncope
NCT02726776Not ApplicableCompleted
Suspension Syndrome
NCT02573649Not ApplicableCompletedPrimary
The Tilt Test-Induced REsponse in Closed-loop Stimulation (TIRECS) Study
Showing all 5 trials